Corticosteroids in polymyalgia rheumatica--a review of different treatment schedules

Clin Exp Rheumatol. Jul-Aug 2000;18(4 Suppl 20):S56-7.

Abstract

Low dose oral steroids (prednisolone 10-15 mg daily) are currently advocated for the treatment of uncomplicated PMR and the dose should be carefully adjusted in relation to disease activity. Intramuscular methylprednisolone has been shown to have a similar remission rate to oral steroids and a better side effect profile with respect to fracture rate and weight gain. Prophylaxis for osteoporosis at least with calcium and vitamin D should be initiated at the start of steroid therapy.

Publication types

  • Review

MeSH terms

  • Drug Administration Schedule
  • Glucocorticoids / administration & dosage*
  • Humans
  • Methylprednisolone / administration & dosage*
  • Polymyalgia Rheumatica / drug therapy*

Substances

  • Glucocorticoids
  • Methylprednisolone